journal
MENU ▼
Read by QxMD icon Read
search

Therapeutic Advances in Endocrinology and Metabolism

journal
https://www.readbyqxmd.com/read/29977500/levothyroxine-pseudo-malabsorption-testing-and-treatment-in-the-outpatient-setting
#1
Grzegorz M Rdzak, Laura M Whitman, Silvio E Inzucchi
Persistent elevation of thyroid stimulating hormone (TSH) is a common clinical problem in outpatient clinics treating patients with primary hypothyroidism. One challenge to practitioners involves predicaments where patients have an inadequate response to a seemingly appropriate dose of levothyroxine (L-T4). A patient's self-assessed compliance to hormone replacement therapy or verification refill history at the patient's pharmacy might not be a reliable form of confirmation of non-adherence to the drug by the patient, which has been referred to as "L-T4 pseudo-malabsorption...
July 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29977499/the-role-of-mitogen-activated-protein-kinase-extracellular-receptor-kinase-pathway-in-female-fertility-outcomes-a-focus-on-pituitary-gonadotropins-regulation
#2
REVIEW
Samira Kahnamouyi, Mohammad Nouri, Laya Farzadi, Masoud Darabi, Vahid Hosseini, Amir Mehdizadeh
Mammalian reproduction systems are largely regulated by the secretion of two gonadotropins, that is, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The main action of LH and FSH on the ovary is to stimulate secretion of estradiol and progesterone, which play an important role in the ovarian function and reproductive cycle control. FSH and LH secretions are strictly controlled by the gonadotropin-releasing hormone (GnRH), which is secreted from the hypothalamus into the pituitary vascular system...
July 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29977498/incidence-mechanisms-and-impact-outcome-of-hyperglycaemia-in-severe-scorpion-envenomed-patients
#3
REVIEW
Mabrouk Bahloul, Olfa Turki, Anis Chaari, Mounir Bouaziz
Hyperglycaemia is often observed in severe scorpion-envenomed patients. It is due to a severe autonomic storm with a massive release of catecholamines, increased glucagon levels, cortisol levels, and either decreased insulin levels or insulin resistance. The presence of hyperglycaemia is an indicator of severity in this specific condition. Indeed, hyperglycaemia was associated with the severity of clinical manifestations of severe scorpion envenomation requiring intensive care unit (ICU) admission. In fact, the presence of hyperglycaemia was associated with the presence of respiratory failure, pulmonary oedema, haemodynamic instability, neurological failure, multisystem organ failure, and an increased mortality and ICU length of stay...
July 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29977497/the-value-of-fast-acting-insulin-aspart-compared-with-insulin-aspart-for-patients-with-diabetes-mellitus-treated-with-bolus-insulin-from-a-uk-health-care-system-perspective
#4
Lalantha Leelarathna, Donna Ashley, Carrie Fidler, Witesh Parekh
Background: Fast-acting insulin aspart is a new formulation of the rapid-acting insulin analogue insulin aspart and represents an advancement over current rapid-acting insulin analogues in terms of onset of action and postprandial glucose control. The objective of the current analysis was to demonstrate the cost impact of prescribing fast-acting insulin aspart instead of insulin aspart, to highlight the value of fast-acting insulin aspart for the treatment of people with diabetes requiring mealtime insulin...
July 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29977496/improved-outcomes-for-papillary-thyroid-microcarcinoma-care-active-surveillance-and-case-volume
#5
EDITORIAL
Francesco Freni, Bruno Galletti, Francesco Galletti, Gianlorenzo Dionigi
No abstract text is available yet for this article.
July 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29854387/comparison-of-day-3-and-day-5-thyroglobulin-results-after-thyrogen-injection-in-differentiated-thyroid-cancer-patients
#6
Sait Sager, Esra Hatipoglu, Burcak Gunes, Sertac Asa, Lebriz Uslu, Kerim Sönmezoğlu
Background: It is necessary to stimulate serum thyroid-stimulating hormone (TSH) levels either endogenously by thyroid hormone withdrawal (THW) or exogenously by administration of recombinant human TSH (rhTSH) for radioactive iodine (RAI) therapy. Thyrotropin alfa (Thyrogen) has many advantages over THW. Radiation dose to laboratory staff while drawing blood for tests on the day 5 is one of the disadvantages of preferring Thyrogen. Our aim was to compare day 3 and day 5 blood test results after Thyrogen injections...
June 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29854386/efficacy-of-gamification-based-smartphone-application-for-weight-loss-in-overweight-and-obese-adolescents-study-protocol-for-a-phase-ii-randomized-controlled-trial
#7
Patrick Timpel, Fernando Henpin Yue Cesena, Christiane da Silva Costa, Matheus Dorigatti Soldatelli, Emanuel Gois, Eduardo Castrillon, Lina Johana Jaime Díaz, Gabriela M Repetto, Fanah Hagos, Raul E Castillo Yermenos, Kevin Pacheco-Barrios, Wafaa Musallam, Zilda Braid, Nesreen Khidir, Marcela Romo Guardado, Roberta Muriel Longo Roepke
Background: Overweight and obesity are significant public health concerns that are prevalent in younger age cohorts. Preventive or therapeutic interventions are difficult to implement and maintain over time. On the other hand, the majority of adolescents in the United States have a smartphone, representing a huge potential for innovative digitized interventions, such as weight loss programs delivered via smartphone applications. Although the number of available smartphone applications is increasing, evidence for their effectiveness in weight loss is insufficient...
June 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29796246/pharmacotherapy-of-type1-diabetes-in-children-and-adolescents-more-than-insulin
#8
REVIEW
Torben Biester, Olga Kordonouri, Thomas Danne
For paediatric patients with type 1 diabetes, intensified insulin therapy with either multiple daily injection or insulin pump therapy is currently the only method of treatment. To optimize this therapy, insulin analogues are fixed parts of all therapy regimens. New ultra-rapid insulins seem to be beneficial not only in adults but also in this age group. New developments in long-acting analogues have demonstrated safety and will be regular in paediatrics, we hope, soon. Furthermore, the psychosocial approach for consideration of real-life aspects becomes more the focus of therapeutic regimens and is implemented into international guidelines...
May 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29796245/the-role-of-basal-insulin-and-glp-1-receptor-agonist-combination-products-in-the-management-of-type-2-diabetes
#9
REVIEW
Taylor R Inman, Erika Plyushko, Nicholas P Austin, Jeremy L Johnson
The prevalence of type 2 diabetes necessitates the development of new treatment options to individualize therapy. Basal insulin has been a standard treatment option for years, while glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have grown in use over the past decade due to glucose-lowering efficacy and weight loss potential. There are two new combination injectable products that have recently been approved combining basal insulins with GLP-1 RAs in single pen-injector devices. United States guidelines recently emphasize the option to use combination injectable therapy with GLP-1 RAs and basal insulin once the basal insulin has been optimally titrated as a second- or third-line agent in addition to metformin without reaching the goal A1c...
May 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29796244/9-and-13-hode-regulate-fatty-acid-binding-protein-4-in-human-macrophages-but-does-not-involve-hode-gpr132-axis-in-ppar-%C3%AE-regulation-of-fabp4
#10
Venkat Vangaveti, Venkatesh Shashidhar, Fiona Collier, Jason Hodge, Catherine Rush, Usman Malabu, Bernhard Baune, Richard Lee Kennedy
Background: Both activation of monocytes and increased serum fatty acid binding protein-4 (FABP4) occur in diabetes and are associated with increased atherosclerosis. The oxidized lipid, 9-hydroxyoctadecadienoic acid (9-HODE) increases FABP4 in macrophages, and is a ligand for G protein-coupled receptor 132 (GPR132). We investigated the involvement of GPR132 in mediating the 9-, 13-HODE stimulation of FABP4 secretion, and whether GPR132 expression is increased in monocytes from patients with type 2 diabetes...
May 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29619209/contemporary-approaches-to-the-management-of-polycystic-ovary-syndrome
#11
REVIEW
Renato Pasquali
Polycystic ovary syndrome (PCOS) is a common disorder in women in their reproductive years and is characterized by androgen excess, ovulatory dysfunction, and polycystic ovarian morphology. It is also associated with several metabolic abnormalities, particularly insulin resistance and obesity, which play an important role in the pathophysiology of PCOS and, in particular, negatively influence ovarian function and fertility. This review article summarizes the available treatment for women with PCOS. Specifically, current and potentially new therapies are discussed...
April 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29619208/conversion-from-insulin-glargine-u-100-to-insulin-glargine-u-300-or-insulin-degludec-and-the-impact-on-dosage-requirements
#12
Scott M Pearson, Jennifer M Trujillo
Background: We wanted to determine whether basal insulin requirements change when patients transition from insulin glargine U-100 (Gla-100) to insulin glargine U-300 (Gla-300) or insulin degludec. Methods: This study involved subjects seen in the University of Colorado Health Endocrine Clinic who were transitioned from Gla-100 to either Gla-300 ( n = 95) or insulin degludec ( n = 39). The primary outcome was the difference between baseline Gla-100 dose and dose of Gla-300 or insulin degludec prescribed after first follow-up visit within 1-12 months...
April 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29619207/awareness-of-diabetic-retinopathy-among-people-with-diabetes-in-jeddah-saudi-arabia
#13
Sami H Alzahrani, Marwan A Bakarman, Saleh M Alqahtani, Maha S Alqahtani, Nadeem Shafique Butt, Emad M Salawati, Ahmad Alkatheri, Ahmad Azam Malik, Khaled Saad
Background: Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM) and the foremost cause of blindness. This study aimed to assess the level of awareness of DR and its related risk factors among patients with DM in Jeddah, Saudi Arabia. Methods: A cross-sectional study was conducted among patients with DM attending primary health care centers at the Ministry of Health in Jeddah. A structured, pretested, self-administered questionnaire was used to collect information on the sociodemographic and DM- and DR-related characteristics of the patients...
April 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29492244/antidiabetic-phytoconstituents-and-their-mode-of-action-on-metabolic-pathways
#14
REVIEW
Sudhanshu Kumar Bharti, Supriya Krishnan, Ashwini Kumar, Awanish Kumar
Diabetes Mellitus, characterized by persistent hyperglycaemia, is a heterogeneous group of disorders of multiple aetiologies. It affects the human body at multiple organ levels thus making it difficult to follow a particular line of the treatment protocol and requires a multimodal approach. The increasing medical burden on patients with diabetes-related complications results in an enormous economic burden, which could severely impair global economic growth in the near future. This shows that today's healthcare system has conventionally been poorly equipped towards confronting the mounting impact of diabetes on a global scale and demands an urgent need for newer and better options...
March 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29492243/a-review-of-the-new-glp-1-receptor-agonist-basal-insulin-fixed-ratio-combination-products
#15
REVIEW
Wesley Nuffer, Ashley Guesnier, Jennifer M Trujillo
There have been several new treatment approaches established for the management of hyperglycemia in type 2 diabetes (T2D), with treatment guidelines listing both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and basal insulin therapies as considerations for patients who have failed to control their blood glucose with oral antidiabetic agents. New studies have highlighted the importance of initiating combination therapy earlier in the T2D disease process to avoid clinical inertia and prevent the long-term complications arising from uncontrolled diabetes...
March 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29387334/hypersensitivity-reactions-to-human-insulin-analogs-in-insulin-na%C3%A3-ve-patients-a-systematic-review
#16
REVIEW
Andrew S Bzowyckyj, Amanda M Stahnke
Objective: The objective of this study was to raise awareness of hypersensitivity reactions to human insulin analogs (HIAs) in insulin-naïve patients and encourage consistent and detailed reporting of HIA reactions. Data sources: A search of PubMed, MEDLINE and International Pharmaceutical Abstracts using the terms 'insulin' and 'hypersensitivity' was completed with English language, humans, and publication date after 1 January 1990 as limits. Study selection and data extraction: The initial search identified 598 articles...
February 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29387333/vascular-affection-in-relation-to-oxidative-dna-damage-in-metabolic-syndrome
#17
Rokayaa Abd El Aziz, Mary Wadie Fawzy, Noha Khalil, Sahar Abdel Atty, Zainab Sabra
Introduction: Obesity has become an important issue affecting both males and females. Obesity is now regarded as an independent risk factor for atherosclerosis-related diseases. Metabolic syndrome is associated with increased risk for development of cardiovascular disease. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine concentration has been used to express oxidation status. Methods: Twenty-seven obese patients with metabolic syndrome, 25 obese patients without metabolic syndrome and 31 healthy subjects were included in our study...
February 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29344338/current-best-practice-in-the-management-of-turner-syndrome
#18
REVIEW
Roopa Kanakatti Shankar, Philippe F Backeljauw
Turner syndrome (TS) is characterized by partial or complete loss of the second X-chromosome in phenotypic females resulting in a constellation of clinical findings that may include lymphedema, cardiac anomalies, short stature, primary ovarian failure and neurocognitive difficulties. Optimizing health care delivery is important to enable these individuals achieve their full potential. We review the current best practice management recommendations for individuals with TS focusing on the latest consensus opinion in regard to genetic diagnosis, treatment of short stature, estrogen supplementation, addressing psychosocial issues, as well screening for other comorbidities...
January 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29344337/financial-burden-of-diabetic-foot-ulcers-to-world-a-progressive-topic-to-discuss-always
#19
REVIEW
Alok Raghav, Zeeshan Ahmad Khan, Rajendra Kumar Labala, Jamal Ahmad, Saba Noor, Brijesh Kumar Mishra
Diabetic foot complications are the most common occurring problems throughout the globe, resulting in devastating economic crises for the patients, families and society. Diabetic foot ulcers (DFUs) have a neuropathic origin with a progressive prevalence rate in developing countries compared with developed countries among diabetes mellitus patients. Diabetic patients that are of greatest risk of ulcers may easily be diagnosed with foot examination. Economic burden may be carefully examined. The budget costing must include both the clinical and social impact of the patients...
January 2018: Therapeutic Advances in Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29344336/treating-nonalcoholic-fatty-liver-disease-in-patients-with-type-2-diabetes-mellitus-a-review-of-efficacy-and-safety
#20
REVIEW
Elizabeth P Mills, K Paige D Brown, Jennifer D Smith, Phillip W Vang, Katie Trotta
Objective: To review current literature for the efficacy and safety of treatment for nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM). Data sources: A PubMed literature search from January 1990 to June 2017 was conducted using the search terms nonalcoholic fatty liver disease, diabetes mellitus, type 2, therapy, treatment, treat, therapeutics, nonalcoholic fatty liver, nonalcoholic hepatosteatosis, NASH, NAFLD, metformin, and statin...
January 2018: Therapeutic Advances in Endocrinology and Metabolism
journal
journal
43053
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"